SOPHIA S. LEE MD NPI 1639167679

NPI Details

Sophia S. Lee, MD is an internal medicine in Middletown, NY with 31 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Sophia S. Lee, MD NPI is 1639167679. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: TULANE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1995

The provider's business location address is:

155 CRYSTAL RUN RD
MIDDLETOWN, NY
ZIP 10941-028
Phone: (845) 703-6999
Fax: (845) 703-6297

The NPI 1639167679 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Follow-up nursing facility visit per day, typically 10 minutes (HCPCS:99307)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Hepatitis c antibody measurement (HCPCS:86803)
• Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Vitamin d-3 level (HCPCS:82306)
• Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Nursing facility discharge day management, 30 minutes or less (HCPCS:99315)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Uric acid level, blood (HCPCS:84550)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Bacterial colony count, urine (HCPCS:87086)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Automated urinalysis test (HCPCS:81003)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)

The enumeration date for this NPI number is 10/13/2005 and was last updated on 10/7/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.